Application

19344040 · DOUBLE-STRANDED RNAI AGENTS AND COMPOSITIONS FOR REDUCING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) AND METHODS OF USE THEREOF

Filed 2025-09-29 · Pending The official file ↗ · Art unit 1635 · Examiner David Tuyang Yu Hard · CPC C12N 15/1136 · SILENCE THERAPEUTICS GMBH · STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

4.9 mo

to disposition n/a

Statutes raised

103

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.